Clinical Trials Browser

Withdrawn × Pancreatic Neoplasms × devimistat × Clear all

NCT06518538 2024-08-15

Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms